Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 170

1.

Recombinant human bone morphogenetic protein-2 released from polyurethane-based scaffolds promotes early osteogenic differentiation of human mesenchymal stem cells.

Kim J, Hollinger JO.

Biomed Mater. 2012 Aug;7(4):045008. doi: 10.1088/1748-6041/7/4/045008. Epub 2012 Jun 1.

PMID:
22652428
2.

Osteogenic differentiation of pre-osteoblasts on biomimetic tyrosine-derived polycarbonate scaffolds.

Kim J, Magno MH, Alvarez P, Darr A, Kohn J, Hollinger JO.

Biomacromolecules. 2011 Oct 10;12(10):3520-7. doi: 10.1021/bm200700d. Epub 2011 Sep 12.

PMID:
21834593
3.

Bony engineering using time-release porous scaffolds to provide sustained growth factor delivery.

Szpalski C, Nguyen PD, Cretiu Vasiliu CE, Chesnoiu-Matei I, Ricci JL, Clark E, Smay JE, Warren SM.

J Craniofac Surg. 2012 May;23(3):638-44. doi: 10.1097/SCS.0b013e31824db8d4.

PMID:
22565873
4.

Improving bone formation in a rat femur segmental defect by controlling bone morphogenetic protein-2 release.

Brown KV, Li B, Guda T, Perrien DS, Guelcher SA, Wenke JC.

Tissue Eng Part A. 2011 Jul;17(13-14):1735-46. doi: 10.1089/ten.TEA.2010.0446. Epub 2011 Apr 3.

PMID:
21338268
5.

The effects of rhBMP-2 released from biodegradable polyurethane/microsphere composite scaffolds on new bone formation in rat femora.

Li B, Yoshii T, Hafeman AE, Nyman JS, Wenke JC, Guelcher SA.

Biomaterials. 2009 Dec;30(35):6768-79. doi: 10.1016/j.biomaterials.2009.08.038. Epub 2009 Sep 17.

PMID:
19762079
6.

Targeted delivery system for juxtacrine signaling growth factor based on rhBMP-2-mediated carrier-protein conjugation.

Liu HW, Chen CH, Tsai CL, Hsiue GH.

Bone. 2006 Oct;39(4):825-36. Epub 2006 Jun 16.

PMID:
16782421
7.

Biological activity of a nanofibrous barrier membrane containing bone morphogenetic protein formed by core-shell electrospinning as a sustained delivery vehicle.

Zhu H, Yu D, Zhou Y, Wang C, Gao M, Jiang H, Wang H.

J Biomed Mater Res B Appl Biomater. 2013 May;101(4):541-52. doi: 10.1002/jbm.b.32854. Epub 2012 Dec 20.

PMID:
23281203
8.

The interactions between rat-adipose-derived stromal cells, recombinant human bone morphogenetic protein-2, and beta-tricalcium phosphate play an important role in bone tissue engineering.

E LL, Xu LL, Wu X, Wang DS, Lv Y, Wang JZ, Liu HC.

Tissue Eng Part A. 2010 Sep;16(9):2927-40. doi: 10.1089/ten.TEA.2010.0018.

PMID:
20486786
9.

Effects of compatibility of deproteinized antler cancellous bone with various bioactive factors on their osteogenic potential.

Zhang X, Xu M, Song L, Wei Y, Lin Y, Liu W, Heng BC, Peng H, Wang Y, Deng X.

Biomaterials. 2013 Dec;34(36):9103-14. doi: 10.1016/j.biomaterials.2013.08.024. Epub 2013 Sep 3.

PMID:
24008040
10.

Customized Ca-P/PHBV nanocomposite scaffolds for bone tissue engineering: design, fabrication, surface modification and sustained release of growth factor.

Duan B, Wang M.

J R Soc Interface. 2010 Oct 6;7 Suppl 5:S615-29. doi: 10.1098/rsif.2010.0127.focus. Epub 2010 May 26.

11.

Comparative study of osteogenic potential of a composite scaffold incorporating either endogenous bone morphogenetic protein-2 or exogenous phytomolecule icaritin: an in vitro efficacy study.

Chen SH, Wang XL, Xie XH, Zheng LZ, Yao D, Wang DP, Leng Y, Zhang G, Qin L.

Acta Biomater. 2012 Aug;8(8):3128-37. doi: 10.1016/j.actbio.2012.04.030. Epub 2012 Apr 24.

PMID:
22543006
12.

Bioactivity of porous biphasic calcium phosphate enhanced by recombinant human bone morphogenetic protein 2/silk fibroin microsphere.

Chen L, Gu Y, Feng Y, Zhu XS, Wang CZ, Liu HL, Niu HY, Zhang C, Yang HL.

J Mater Sci Mater Med. 2014 Jul;25(7):1709-19.

PMID:
24659100
13.

Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro.

Kim HD, Valentini RF.

J Biomed Mater Res. 2002 Mar 5;59(3):573-84.

PMID:
11774316
14.

Dose- and time-dependent effects of recombinant human bone morphogenetic protein-2 on the osteogenic and adipogenic potentials of alveolar bone-derived stromal cells.

Park JC, Kim JC, Kim BK, Cho KS, Im GI, Kim BS, Kim CS.

J Periodontal Res. 2012 Oct;47(5):645-54. doi: 10.1111/j.1600-0765.2012.01477.x. Epub 2012 Apr 4.

PMID:
22471302
15.

Reconstruction of alveolar bone defects using bone morphogenetic protein 2 mediated rabbit dental pulp stem cells seeded on nano-hydroxyapatite/collagen/poly(L-lactide).

Liu HC, E LL, Wang DS, Su F, Wu X, Shi ZP, Lv Y, Wang JZ.

Tissue Eng Part A. 2011 Oct;17(19-20):2417-33. doi: 10.1089/ten.TEA.2010.0620. Epub 2011 Jun 16.

PMID:
21563858
16.

In situ controlled release of rhBMP-2 in gelatin-coated 3D porous poly(ε-caprolactone) scaffolds for homogeneous bone tissue formation.

Zhang Q, Tan K, Zhang Y, Ye Z, Tan WS, Lang M.

Biomacromolecules. 2014 Jan 13;15(1):84-94. doi: 10.1021/bm401309u. Epub 2013 Nov 27.

PMID:
24266740
17.

Combined mesenchymal stem cell sheets and rhBMP-2-releasing calcium sulfate-rhBMP-2 scaffolds for segmental bone tissue engineering.

Qi Y, Wang Y, Yan W, Li H, Shi Z, Pan Z.

Cell Transplant. 2012;21(4):693-705. doi: 10.3727/096368911X623844. Epub 2012 Jan 10.

PMID:
22236577
18.

Segmental bone regeneration using an rhBMP-2-loaded gelatin/nanohydroxyapatite/fibrin scaffold in a rabbit model.

Liu Y, Lu Y, Tian X, Cui G, Zhao Y, Yang Q, Yu S, Xing G, Zhang B.

Biomaterials. 2009 Oct;30(31):6276-85. doi: 10.1016/j.biomaterials.2009.08.003. Epub 2009 Aug 15.

PMID:
19683811
19.

Limited but heterogeneous osteogenic response of human bone marrow mesenchymal stem cells to bone morphogenetic protein-2 and serum.

Mizuno D, Agata H, Furue H, Kimura A, Narita Y, Watanabe N, Ishii Y, Ueda M, Tojo A, Kagami H.

Growth Factors. 2010 Feb;28(1):34-43. doi: 10.3109/08977190903326362.

PMID:
19835486
20.
Items per page

Supplemental Content

Write to the Help Desk